🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase I open-label, multicenter study designed to evaluate the sa...
Status
Terminated
Location
Colorado Blood Cancer Institute (CBCI) at Presbyterian/ St. Luke's Medical Center
Start Date
2019-07-22
Trial ID
NCT04045028
Treatments Being Tested
Primary Objective: -To demonstrate the benefit of isatuximab in combinatio...
Status
Active Not Recruiting
Location
Investigational Site Number: 8400006
Start Date
2017-12-07
Trial ID
NCT03319667
Treatments Being Tested
The primary objective of this study is to determine whether treatment with ...
Status
Completed
Location
Arizona Oncology Associates, PC - HAL
Start Date
2017-11-07
Trial ID
NCT03301220
Treatments Being Tested
Pemphigus is characterized by the presence of IgG antibodies that lead to t...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-10-01
Trial ID
NCT06663943
Treatments Being Tested
This is an open-label, pilot study designed to explore whether daratumumab ...
Status
Completed
Location
The Litwin-Zucker Research Center
Start Date
2019-11-06
Trial ID
NCT04070378
Treatments Being Tested
The purpose of the study is to evaluate the pharmacokinetics and safety fro...
Status
Completed
Location
Multiple Locations
Start Date
2015-10-22
Trial ID
NCT02519452
The purpose of this research is to study the safety and efficacy of daratum...
Status
Recruiting
Location
Mayo Clinic
Start Date
2023-08-17
Trial ID
NCT05654506
Treatments Being Tested
The purpose of this study is to determine the activity of tamibarotene in p...
Status
Completed
Location
Multiple Locations
Start Date
2016-09-20
Trial ID
NCT02807558
Treatments Being Tested
Multiple myeloma (MM) accounts for more than 10% of all blood cancers and 1...
Status
Terminated
Location
Sylvester Comprehensive Cancer Center /ID# 228817
Start Date
2022-01-17
Trial ID
NCT04895410
Treatments Being Tested
This is an open-label, multicenter, Phase 2 study in subjects with newly di...
Status
Recruiting
Location
Peking Union Medical College Hospital
Start Date
2024-06-15
Trial ID
NCT06418477
Treatments Being Tested